6:45-7:45 a.m.

Non-CME Symposium Hosted by Epizyme
The First and Only EZH2 Inhibitor Indicated for Patients with Relapsed or Refractory Follicular Lymphoma
Marin Xavier, MD
John Pagel, MD, PhD

6:45 a.m.

Virtual Event Opens & View Exhibits

7:40 a.m.

Welcome & Morning Announcements

7:45 a.m.

The Race Toward Equity: Increasing Racial Diversity in Cancer Research and Cancer Care
Lori J. Pierce, MD

8:15 a.m.

The Evolving Paradigm of Melanoma Treatment
Janice Mehnert, MD

8:45 a.m.

Immunotherapy and Targeted Therapy in Upper GI Cancers
Sam Klempner, MD

9:15 a.m.

Break, Networking & View Exhibits

9:30 a.m.

How to Prioritize the Many Therapeutic Options for HER2+ Metastatic Breast Cancer
Debasish Tripathy, MD

10 a.m.

Management of Non-Clear Cell RCC
Sumanta Kumar Pal, MD

10:30 a.m.

Updates in NSCLC with Emphasis on Front Line Therapy
Suresh S. Ramalingam, MD

11 a.m.

Solid Tumor Oncology Panel Part 1
Janice Mehnert, MD
Sam Klempner, MD
Suresh S. Ramalingam, MD
Debasish Tripathy, MD

11:30 a.m.

Break, Networking & View Exhibits

11:30 a.m. - 12:30 p.m.

Non-CME Symposium Hosted by Bristol-Myers Squibb
A Treatment Option for Patients with Myelodysplastic Syndromes
Bart Scott, MD

11:30 a.m. - 12:30 p.m.

Non-CME Symposium Hosted by Exelixis
A New Combination Treatment for Patients with Advanced Renal Cell Carcinoma
Michael Harrison, MD

12:30 p.m.

Targeted Approaches in Sarcoma
Arun S. Singh, MD

1 p.m.

Optimizing Immunotherapy for Metastatic Breast Cancer
Heather L. McArthur, MD, MPH

1:30 p.m.

Practical Aspects of Novel Imaging Approaches in the Management of Prostate Cancer
Jeremie Calais, MD, MSc

2 p.m.

Break, Networking & View Exhibits

2:15 p.m.

Update on Systemic Therapies for Thyroid Cancer
Eric J. Sherman, MD

2:45 p.m.

New Approaches to Recurrent or Advanced Bladder Cancer
Dean F. Bajorin, MD

3:15 p.m.

The Evolving Role of Liquid Biopsies
David R. Gandara, MD, FASCO

3:45 p.m.

Solid Tumor Oncology Panel Part 2
Jeremie Calais, MD, MSc
Heather L. McArthur, MD, MPH
Eric J. Sherman, MD
Arun S. Singh, MD

4:15 p.m.

Main Conference Final Adjournment